Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Rayburn

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
The Nebraska Medical Journal|February 1, 1986
Drugs during pregnancy: are any really safe?W F Rayburn
American Journal of Obstetrics and Gynecology|March 1, 1989
Prostaglandin E2 gel for cervical ripening and induction of labor: a critical analysisW F Rayburn
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|October 1, 1992
Glucocorticoid therapy for rheumatic diseases: maternal, fetal, and breast-feeding considerationsW F Rayburn
Clinical Obstetrics and Gynecology|December 1, 1987
Monitoring fetal body movementW F Rayburn
American Journal of Perinatology|February 1, 1996
Clinical commentary: the bromocriptine (Parlodel) controversy and recommendations for lactation suppressionW F Rayburn
The Journal of Reproductive Medicine|September 1, 1982
Surveillance techniques other than ultrasonography for detecting fetal malformationsW F Rayburn
Obstetrics and Gynecology|June 1, 1993
A physician's prerogative to prescribe drugs for off-label uses during pregnancyW F Rayburn
Clinical and Experimental Hypertension. Part B, Hypertension in Pregnancy|January 1, 1982
Fetal activity patterns in hypertensive pregnanciesW F Rayburn
The Journal of Reproductive Medicine|June 4, 1998
Sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. A summaryW F Rayburn
The Journal of Reproductive Medicine|February 25, 1998
American Heart Association: new guidelines for prevention of bacterial endocarditisW F Rayburn
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
The Nebraska Medical Journal|February 1, 1986
Drugs during pregnancy: are any really safe?W F Rayburn
American Journal of Obstetrics and Gynecology|March 1, 1989
Prostaglandin E2 gel for cervical ripening and induction of labor: a critical analysisW F Rayburn
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|October 1, 1992
Glucocorticoid therapy for rheumatic diseases: maternal, fetal, and breast-feeding considerationsW F Rayburn
Clinical Obstetrics and Gynecology|December 1, 1987
Monitoring fetal body movementW F Rayburn
American Journal of Perinatology|February 1, 1996
Clinical commentary: the bromocriptine (Parlodel) controversy and recommendations for lactation suppressionW F Rayburn
The Journal of Reproductive Medicine|September 1, 1982
Surveillance techniques other than ultrasonography for detecting fetal malformationsW F Rayburn
Obstetrics and Gynecology|June 1, 1993
A physician's prerogative to prescribe drugs for off-label uses during pregnancyW F Rayburn
Clinical and Experimental Hypertension. Part B, Hypertension in Pregnancy|January 1, 1982
Fetal activity patterns in hypertensive pregnanciesW F Rayburn
The Journal of Reproductive Medicine|June 4, 1998
Sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. A summaryW F Rayburn
The Journal of Reproductive Medicine|February 25, 1998
American Heart Association: new guidelines for prevention of bacterial endocarditisW F Rayburn
Pageof 16